Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26834 | 0.87 | SERPINE1 (0.38) | EPHX1MEN1KMT2ASERPINE1CHRM3 | |
| SCHEMBL1138479 | 0.87 | SERPINE1 (0.38) | EPHX1MEN1KMT2ASERPINE1CHRM3 | |
| SCHEMBL374062 | 0.87 | — | — | |
| SCHEMBL126557 | 0.87 | SERPINE1 (0.38) | EPHX1MEN1KMT2ASERPINE1CHRM3 | |
| SCHEMBL13195790 | 0.86 | CYP19A1 (0.46) | CYP19A1LMNARAB9AEPHX1 | |
| Hydrochloric Acid SCHEMBL4395687 | 0.84 | — | — | |
| SCHEMBL14991180 | 0.82 | CYP19A1 (0.44) | CYP19A1ALDH1A1NPC1LMNAMAPT | |
| SCHEMBL14991039 | 0.82 | CYP19A1 (0.44) | CYP19A1ALDH1A1NPC1LMNAMAPT | |
| SCHEMBL9723253 | 0.82 | CYP19A1 (0.44) | CYP19A1ALDH1A1NPC1LMNAMAPT | |
| Cyclohexane SCHEMBL7797729 | 0.81 | EPHX1 (0.43) | CYP19A1SMN1; SMN2EPHX1SERPINE1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230382940-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. | 2023-11-30 | — | — | US | disclosed |
| WO-2023168254-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | GILEAD SCIENCES, INC. (US) | 2023-09-07 | — | — | WO | disclosed |
| EP-3279181-B1 | METHOD FOR PRODUCING A MIXTURE OF A POLYMERIZABLE COMPOUND | ZEON CORP (JP) | 2021-08-04 | — | — | EP | disclosed |
| US-5098886-A | Mixing compounds to improve odor | INTERNATIONAL FLAVORS & FRAGRANCES INC., A CORP. OF NEW YORK | 1992-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382940-A1 | ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | EIF2AK2, MAVS, ZC3HAV1 | CYP19A1 4401/4885ALDH1A1 3135/4885NPC1 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.